Company / CapEx per Share
Sana Biotechnology, Inc. CapEx per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.14
FY2024
5-year range
$0.10 / $1.83
FY2020-FY2024
Trend
+40.6%
vs FY2023
Sector context
#49 of 192
Health Care
What the data says
At $0.14, Sana Biotechnology, Inc.'s capex per share ranks #49 of 192 in the Health Care sector. CapEx per Share returned to growth in FY2024 after 4 years of decline, reaching $0.14.
Based on SEC 10-K filings.
0.14 in FY2024 with a 5-year CAGR of -51.4%.
Improved from $0.11 to $0.14 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -6.9%
- 5-Year CAGR
- -51.4%
- 10-Year CAGR
- -
Sector benchmark
#49 of 192 in Health CareTop 26% of 192This company $0.14 Sector average $3.54
▼
-95.9% below sector average
Key checks
Key Insights
- In FY2024, capex per share increased 40.6% year-over-year.
- Ranks #49 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
- Lowest capex per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.14 | +40.6% |
| FY2023 | $0.10 | -7.1% |
| FY2022 | $0.11 | -38.2% |
| FY2021 | $0.18 | -90.2% |
| FY2020 | $1.83 | -65.6% |
| FY2019 | $5.33 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026